Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-31

Clinical Trial Update: Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 trial investigating rapid reversal of CNS-depressant drug effects before brain death determination has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Prisma Health-Midlands | Conditions: Brain Death, Anoxic Brain Injury | EARLY_Phase 1 | Status: WITHDRAWN